13. 多発性硬化症/視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details


臨床試験数 : 3,342 薬物数 : 2,380 - (DrugBank : 407) / 標的遺伝子数 : 266 - 標的パスウェイ数 : 240

  
5 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2007-005414-40-IT
(EUCTR)
21/12/200728/11/2007Efficacy and activity of levetiracetam on Multiple Sclerosis cerebellar symptoms: a multicenters double blind, randomized, placebo-controlled, cross over study - NDEfficacy and activity of levetiracetam on Multiple Sclerosis cerebellar symptoms: a multicenters double blind, randomized, placebo-controlled, cross over study - ND Patients with an established and stable Multiple Sclerosis (according to Poser criteria).
MedDRA version: 9.1;Level: LLT;Classification code 10028245;Term: Multiple sclerosis
Trade Name: KEPPRA
INN or Proposed INN: Levetiracetam
AZIENDA SANITARIA N. 3 GENOVESENULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Italy
2NCT00423527
(ClinicalTrials.gov)
January 200716/1/2007Levetiracetam in Central Pain in Multiple Sclerosis(MS)Double-blind, Randomised,Placebo-controlled Trial of Levetiracetam in Central Pain in Multiple SclerosisMultiple SclerosisDrug: levetiracetamOdense University HospitalNULLCompleted18 YearsN/ABoth30Phase 4Denmark
3EUCTR2006-000397-71-DK
(EUCTR)
16/05/200602/05/2006Double-blind, randomised, placebo-controlled trial of levetiracetam for central neuropathic pain in patients with multiple sclerosis - levetiracetam for central neuropathic pain in patients with multiple sclerosisDouble-blind, randomised, placebo-controlled trial of levetiracetam for central neuropathic pain in patients with multiple sclerosis - levetiracetam for central neuropathic pain in patients with multiple sclerosis Trade Name: Keppra
Product Name: Levetiracetam
Product Code: ucb L059
Søren H. Sindrup, Department of Neurology, Odense University HospitalNULLNot RecruitingFemale: yes
Male: yes
30Denmark
4EUCTR2005-003903-35-GB
(EUCTR)
19/01/200619/12/2005 : The Role of Keppra in the Treatment of Tremor in Multiple Sclerosis : The Role of Keppra in the Treatment of Tremor in Multiple Sclerosis Multiple SclerosisTrade Name: Keppra 250mg
INN or Proposed INN: Levetiracetam
Trade Name: Keppra 500mg
Product Name: Keppra ®
Newcastle-upon-Tyne Hospitals NHS TrustNULLNot Recruiting Female: yes
Male: yes
20 Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): yesUnited Kingdom
5EUCTR2005-001776-13-DE
(EUCTR)
05/08/200526/09/2006Efficacy of Levetiracetam in the treatment of spasticity in MS: a ranomized double blind cross over studyEfficacy of Levetiracetam in the treatment of spasticity in MS: a ranomized double blind cross over study Multiple SclerosisProduct Name: LevetiracetamOrganisation name was not enteredNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
24Germany